| Product Code: ETC8683194 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Oman Antithrombotic Drugs Market Overview |
3.1 Oman Country Macro Economic Indicators |
3.2 Oman Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Oman Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Oman Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Oman Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Oman Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Oman Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Oman Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Oman Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Oman Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Oman Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Oman |
4.2.2 Growing geriatric population in Oman |
4.2.3 Technological advancements in antithrombotic drugs |
4.2.4 Rising awareness about the importance of antithrombotic therapy |
4.2.5 Government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost of antithrombotic drugs |
4.3.2 Adverse effects associated with antithrombotic medications |
4.3.3 Limited access to healthcare facilities in rural areas of Oman |
4.3.4 Stringent regulatory requirements for drug approval |
4.3.5 Competition from alternative therapies |
5 Oman Antithrombotic Drugs Market Trends |
6 Oman Antithrombotic Drugs Market, By Types |
6.1 Oman Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Oman Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Oman Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Oman Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Oman Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Oman Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Oman Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Oman Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Oman Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Oman Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Oman Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Oman Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Oman Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Oman Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Oman Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Oman Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Oman Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Oman Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Oman Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Oman Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Oman Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Oman Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Oman Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Oman Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Oman Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Oman Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Oman Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Oman Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Oman Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Oman Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Oman Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Oman Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Oman Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Oman Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Oman Antithrombotic Drugs Market Export to Major Countries |
7.2 Oman Antithrombotic Drugs Market Imports from Major Countries |
8 Oman Antithrombotic Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to antithrombotic therapy |
8.2 Number of healthcare professionals trained in prescribing antithrombotic drugs |
8.3 Rate of hospitalizations due to thrombotic events |
8.4 Percentage of population screened for cardiovascular risk factors |
8.5 Adoption rate of newer antithrombotic drugs in clinical practice |
9 Oman Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Oman Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Oman Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Oman Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Oman Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Oman Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Oman Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Oman Antithrombotic Drugs Market - Competitive Landscape |
10.1 Oman Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Oman Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here